Literature DB >> 11742503

Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates.

M Carcenac1, M Dorvillius, V Garambois, F Glaussel, C Larroque, R Langlois, N E Hynes, J E van Lier, A Pèlegrin.   

Abstract

Immunophototherapy of cancer combines the specificity of a monoclonal antibody (MAb) to an overexpressed tumor marker with the phototoxic properties of the conjugated dye. To analyze the potential role of internalisation of the dye on photo-induced cytotoxicity, we compared two target antigens, carcinoembryonic antigen (CEA) that does not internalise and ErbB2 that does. Human ovarian carcinoma SKOv3 cells that express a high level of ErbB2 were transfected with the CEA cDNA. Using FACS analysis, the resulting cell line, SKOv3-CEA-1B9, demonstrated comparable levels of expression of the two target antigens. Aluminium tetrasulfophthalocyanine (AlPcS(4)) was covalently coupled to anti-CEA MAb 35A7, anti-ErbB2 MAb FSP77 and a non-specific MAb PX, via a five-carbon sulfonamide spacer chain (A(1)) at molar ratios ranging from 6 to 9 moles of AlPcS(4) per mole of MAb. The 35A7-(AlPcS(4)A(1))(8) conjugate induced 68% growth inhibition of the SKOv3-CEA-1B9 cell line after a 20 h incubation at 2.50 microg/ml (based on AlPcS(4)A(1) content) following light exposure. However, the FSP77-(AlPcS(4)A(1))(6) conjugate gave a 51% growth inhibition for an AlPcS(4)A(1) concentration as low as 0.04 microg/ml after the same incubation time and exposure to the same light dose. At a 1.25 microg/ml AlPcS(4)A(1) concentration, the FSP77-(AlPcS(4)A(1))(6) conjugate gave a 67% growth inhibition after an incubation time as short as 1 h, reaching a 96% inhibition after an 8 h incubation time. Using an unique cell line that expresses two different target antigens, we demonstrated a clear advantage of an internalising over a non-internalising MAb-dye conjugate in terms of phototoxic efficacy. In vivo evaluation of the photodynamic properties of the conjugates is in progress. (c) 2001 Cancer Research Campaign

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742503      PMCID: PMC2363963          DOI: 10.1054/bjoc.2001.2170

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Monoclonal antibodies against the extracellular domain of the erbB-2 receptor function as partial ligand agonists.

Authors:  I M Harwerth; W Wels; B M Marte; N E Hynes
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

2.  Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.

Authors:  M Carcenac; C Larroque; R Langlois; J E van Lier; J C Artus; A Pèlegrin
Journal:  Photochem Photobiol       Date:  1999-12       Impact factor: 3.421

3.  Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates.

Authors:  A R Oseroff; D Ohuoha; T Hasan; J C Bommer; M L Yarmush
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

4.  Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines.

Authors:  G Köhler; S C Howe; C Milstein
Journal:  Eur J Immunol       Date:  1976-04       Impact factor: 5.532

5.  Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy.

Authors:  M B Vrouenraets; G W Visser; F A Stewart; M Stigter; H Oppelaar; P E Postmus; G B Snow; G A van Dongen
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

6.  Antibody-fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice.

Authors:  A Pèlegrin; S Folli; F Buchegger; J P Mach; G Wagnières; H van den Bergh
Journal:  Cancer       Date:  1991-05-15       Impact factor: 6.860

7.  Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy.

Authors:  M B Vrouenraets; G W Visser; C Loup; B Meunier; M Stigter; H Oppelaar; F A Stewart; G B Snow; G A van Dongen
Journal:  Int J Cancer       Date:  2000-10-01       Impact factor: 7.396

8.  Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate.

Authors:  M Del Governatore; M R Hamblin; C R Shea; I Rizvi; K G Molpus; K K Tanabe; T Hasan
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

9.  Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates.

Authors:  D Mew; C K Wat; G H Towers; J G Levy
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

10.  Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer.

Authors:  M R Hamblin; M Del Governatore; I Rizvi; T Hasan
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

View more
  18 in total

1.  Evaluation of oxygen dependence on in vitro and in vivo cytotoxicity of photoimmunotherapy using IR-700-antibody conjugates.

Authors:  Shun Kishimoto; Marcelino Bernardo; Keita Saito; Sho Koyasu; James B Mitchell; Peter L Choyke; Murali C Krishna
Journal:  Free Radic Biol Med       Date:  2015-04-08       Impact factor: 7.376

2.  3D mesoscopic fluorescence tomography for imaging micro-distribution of antibody-photon absorber conjugates during near infrared photoimmunotherapy in vivo.

Authors:  Qinggong Tang; Tadanobu Nagaya; Yi Liu; Hannah Horng; Jonathan Lin; Kazuhide Sato; Hisataka Kobayashi; Yu Chen
Journal:  J Control Release       Date:  2018-04-16       Impact factor: 9.776

3.  Real-time monitoring of microdistribution of antibody-photon absorber conjugates during photoimmunotherapy in vivo.

Authors:  Qinggong Tang; Tadanobu Nagaya; Yi Liu; Jonathan Lin; Kazuhide Sato; Hisataka Kobayashi; Yu Chen
Journal:  J Control Release       Date:  2017-06-08       Impact factor: 9.776

4.  Synthesis and biological investigations of a ZnPc-antiCEA bioconjugate for imaging of colorectal cancer.

Authors:  Inder Sehgal; Hairong Li; Benson Ongarora; Daniel Devillier; M Graça H Vicente
Journal:  J Porphyr Phthalocyanines       Date:  2013-01-01       Impact factor: 1.811

Review 5.  Combination of photodynamic therapy and immunomodulation: current status and future trends.

Authors:  Yong-Gang Qiang; Christine M N Yow; Zheng Huang
Journal:  Med Res Rev       Date:  2008-07       Impact factor: 12.944

Review 6.  Shedding light on nanomedicine.

Authors:  Rong Tong; Daniel S Kohane
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-08-09

7.  Metallo-phthalocyanine near-IR fluorophores: oligonucleotide conjugates and their applications in PCR assays.

Authors:  Irina V Nesterova; Vera T Verdree; Serhii Pakhomov; Karen L Strickler; Michael W Allen; Robert P Hammer; Steven A Soper
Journal:  Bioconjug Chem       Date:  2007-11-21       Impact factor: 4.774

8.  Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics.

Authors:  Leanne B Josefsen; Ross W Boyle
Journal:  Theranostics       Date:  2012-10-04       Impact factor: 11.556

Review 9.  Photodynamic Therapy and the Biophysics of the Tumor Microenvironment.

Authors:  Aaron J Sorrin; Mustafa Kemal Ruhi; Nathaniel A Ferlic; Vida Karimnia; William J Polacheck; Jonathan P Celli; Huang-Chiao Huang; Imran Rizvi
Journal:  Photochem Photobiol       Date:  2020-03-05       Impact factor: 3.421

10.  Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules.

Authors:  Makoto Mitsunaga; Mikako Ogawa; Nobuyuki Kosaka; Lauren T Rosenblum; Peter L Choyke; Hisataka Kobayashi
Journal:  Nat Med       Date:  2011-11-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.